GEN Exclusives

More »

GEN News Highlights

More »
Apr 11, 2011

Lonza to Distribute Roche’s Mycoplasma Testing Solutions

  • Roche and Lonza entered into a co-exclusive distribution agreement for the commercialization of Roche’s MycoTOOL mycoplasma PCR assays. The detection kits will be made available through Lonza for final-release testing of pharmaceutical products. Additionally, Lonza will offer contract testing services. MycoTOOL test is a NAT-based detection system that is used for mycoplasma biosafety testing of approved biological products.

    Release testing with MycoTOOL has been approved by the EMA for several pharmaceutical products. The product design, production process, change control notification procedure, premium quality products, logistics, and fulfillment systems help ensure that the products retain their proven high quality, Roche and Lonza explain.

    Mycoplasmas are frequent causes of contamination in biopharmaceutical production, cell therapy, and tissue engineering. Traditional detection methods required by pharmacopoeias and regulatory authorities worldwide use growth on culture media to detect contamination. These culture-based techniques require a minimum of 28 days to complete.

    The PCR-based MycoTOOL test can be used in place of traditional mycoplasma testing methods. “Lonza’s reputation for quality and customer care gives us confidence that MycoTOOL will be placed in the right applications for customers who wish to perform rapid mycoplasma testing in-house and for those who prefer to send their samples to a qualified outside laboratory for testing,” says Robert Yates, head of Roche Applied Science.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »